tDCS Treatment for Cognitive Impairment After Stroke
TDCS to Improve Post-Stroke Cognitive Impairment
Recruiting
N/A
Interventional Study
Stroke
Stroke Sequelae
Cognitive Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Johns Hopkins University · Other
Who this trial is looking for
This trial is looking for adults who have had a mild stroke and are experiencing cognitive impairment. Participants will receive brain stimulation treatment along with cognitive exercises or a placebo with the same exercises, and their progress will be monitored over time.
Are You a Good Fit for This Trial?
You may be able to join if
- I am an adult aged 18 or older.
- I had a mild stroke within the last week.
- I have a brain MRI showing evidence of my stroke.
- I speak English natively.
- I have a score of less than 8 on the NIHSS scale about a month after my stroke.
- I have a score of 0-2 on the mRS scale about a month after my stroke.
You may not be able to join if
- I have had a primary bleeding stroke.
- I have a large blockage in a major blood vessel.
- I have language difficulties or neglect due to my stroke.
- I have a history of dementia or serious untreated mental illness.
- I have uncorrected hearing or vision problems.
- I cannot attend treatment or follow-up sessions.
- I cannot travel to College Park for necessary tests.
- I have any metal implants or conditions that may affect the MEG machine.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
The investigators will conduct a randomized, double-blinded, sham-controlled trial of approximately 60 patients with minor stroke and post-stroke mild cognitive impairment (psMCI). Participants will be individually randomized on enrollment using a random number generator to treatment with anodal tDCS + computerized cognitive treatment (CCT) versus sham + CCT (approximately 30 patients in each arm)…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Adults (≥18 years) presenting with neurological symptoms due to acute ischemic stroke (symptom onset within the week prior to admission).
2. Evidence on brain MRI of acute ischemic stroke (imaging negative strokes and TIAs will be excluded).
3. Native English speaker (by self…
Contacts